Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2010

01-08-2010 | Epidemiology

Diagnostic work-up of contralateral breast cancers has not improved over calendar period

Authors: Maria E. C. Sandberg, Mikael Hartman, Gustaf Edgren, Sandra Eloranta, Alexander Ploner, Per Hall, Kamila Czene

Published in: Breast Cancer Research and Treatment | Issue 3/2010

Login to get access

Abstract

Women who have been treated for breast cancer are typically followed up with regular mammography and palpation, with the aim of detecting recurrences and contralateral breast cancer (CBC). This study aims to investigate if the diagnostic work-up of breast cancer patients has improved over the last 25 years and resulted in earlier diagnoses of CBC. Two population-based cohorts were used; all CBCs in Sweden 1976–2004 (n: 2932), and all CBCs in Stockholm, Sweden, 1976–2005 (n: 626), both cohorts with a maximum of 3 years between the two cancers. Synchronous CBC was defined as two cancers <3 months apart, the remainder was defined as metachronous CBC. We calculated the odds ratio of being diagnosed synchronously, relative to metachronously, using logistic regression, adjusting for whether the second cancer was detected through clinical work-up or not. The odds of synchronous CBC were significantly increased: 1.27 (95% CI, 1.13–1.42) per 5-year period, compared to metachronous, and was not affected by detection mode, but seemed to be explained by adjuvant therapy. The proportion of CBCs detected by clinical work-up did not increase over the study period, and the mean size of the second tumor remained constant. We found an increase in the proportion of synchronous CBCs compared to metachronous, over calendar period, a change that was not associated with clinical work-up, but with adjuvant therapy. This study gives no indications that any improvement in diagnostic work-up of CBC have occurred over the last 25 years.
Literature
1.
go back to reference Hungness ES, Safa M, Shaughnessy EA, Aron BS, Gazder PA, Hawkins HH, Lower EE, Seeskin C, Yassin RS, Hasselgren PO (2000) Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 128:702–707CrossRefPubMed Hungness ES, Safa M, Shaughnessy EA, Aron BS, Gazder PA, Hawkins HH, Lower EE, Seeskin C, Yassin RS, Hasselgren PO (2000) Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 128:702–707CrossRefPubMed
2.
go back to reference Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH (2003) Synchronous, bilateral breast cancer: prognostic value and incidence. Breast 12:83–88CrossRefPubMed Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH (2003) Synchronous, bilateral breast cancer: prognostic value and incidence. Breast 12:83–88CrossRefPubMed
3.
go back to reference Polednak AP (2003) Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 133:383–389CrossRefPubMed Polednak AP (2003) Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 133:383–389CrossRefPubMed
4.
go back to reference Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE (1997) Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 4:198–202CrossRefPubMed Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE (1997) Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol 4:198–202CrossRefPubMed
5.
go back to reference Adami HO, Bergstrom R, Hansen J (1985) Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer 55:643–647CrossRefPubMed Adami HO, Bergstrom R, Hansen J (1985) Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer 55:643–647CrossRefPubMed
6.
go back to reference Chen Y, Semenciw R, Kliewer E, Shi Y, Mao Y (2001) Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada. Breast Cancer Res Treat 67:35–40CrossRefPubMed Chen Y, Semenciw R, Kliewer E, Shi Y, Mao Y (2001) Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada. Breast Cancer Res Treat 67:35–40CrossRefPubMed
7.
go back to reference Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami HO, Dickman PW, Hall P (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25:4210–4216CrossRefPubMed Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami HO, Dickman PW, Hall P (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25:4210–4216CrossRefPubMed
8.
go back to reference Robbins GF, Berg JW (1964) Bilateral primary breast cancer; a prospective clinicopathological study. Cancer 17:1501–1527CrossRefPubMed Robbins GF, Berg JW (1964) Bilateral primary breast cancer; a prospective clinicopathological study. Cancer 17:1501–1527CrossRefPubMed
9.
go back to reference Swedish Organised Service Screening Evaluation Group (2007) Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 109:2205–2212CrossRef Swedish Organised Service Screening Evaluation Group (2007) Effect of mammographic service screening on stage at presentation of breast cancers in Sweden. Cancer 109:2205–2212CrossRef
10.
go back to reference Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Hakansson S (2000) Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 7:14–18CrossRefPubMed Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Hakansson S (2000) Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 7:14–18CrossRefPubMed
11.
go back to reference Hendrick RE, Berns EA (2000) Optimizing techniques in screen-film mammography. Radiol Clin North Am 38:701–718 (viii)CrossRefPubMed Hendrick RE, Berns EA (2000) Optimizing techniques in screen-film mammography. Radiol Clin North Am 38:701–718 (viii)CrossRefPubMed
12.
go back to reference Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R (2006) Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987–2000. J Clin Oncol 24:872–877CrossRefPubMed Harlan LC, Clegg LX, Abrams J, Stevens JL, Ballard-Barbash R (2006) Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987–2000. J Clin Oncol 24:872–877CrossRefPubMed
13.
go back to reference Kemetli L, Rutqvist LE, Jonsson H, Nystrom L, Lenner P, Tornberg S (2009) Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976–2005. Acta Oncol 48:59–66CrossRefPubMed Kemetli L, Rutqvist LE, Jonsson H, Nystrom L, Lenner P, Tornberg S (2009) Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976–2005. Acta Oncol 48:59–66CrossRefPubMed
14.
go back to reference Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J (2002) Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999. J Natl Cancer Inst 94:1626–1634PubMed Mariotto A, Feuer EJ, Harlan LC, Wun LM, Johnson KA, Abrams J (2002) Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999. J Natl Cancer Inst 94:1626–1634PubMed
15.
go back to reference Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ (2004) Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91:242–247PubMed Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ (2004) Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91:242–247PubMed
16.
go back to reference Mattsson B, Wallgren A (1984) Completeness of the Swedish cancer register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23:305–313CrossRefPubMed Mattsson B, Wallgren A (1984) Completeness of the Swedish cancer register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23:305–313CrossRefPubMed
17.
go back to reference Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol 48:27–33CrossRefPubMed Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish cancer register: a sample survey for year 1998. Acta Oncol 48:27–33CrossRefPubMed
18.
go back to reference Jonsson H, Johansson R, Lenner P (2005) Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117:842–847CrossRefPubMed Jonsson H, Johansson R, Lenner P (2005) Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 117:842–847CrossRefPubMed
19.
20.
go back to reference Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE (2008) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110:189–197CrossRefPubMed Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE (2008) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110:189–197CrossRefPubMed
21.
go back to reference Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717CrossRef Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717CrossRef
22.
go back to reference Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225:165–175CrossRefPubMed Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225:165–175CrossRefPubMed
23.
go back to reference Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA (2006) Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 17:1281–1290CrossRefPubMed Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA (2006) Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 17:1281–1290CrossRefPubMed
24.
go back to reference Robinson A, Speers C, Olivotto I, Chia S (2007) Method of detection of new contralateral primary breast cancer in younger versus older women. Clin Breast Cancer 7:705–709CrossRefPubMed Robinson A, Speers C, Olivotto I, Chia S (2007) Method of detection of new contralateral primary breast cancer in younger versus older women. Clin Breast Cancer 7:705–709CrossRefPubMed
25.
go back to reference Roubidoux MA, Helvie MA, Lai NE, Paramagul C (1995) Bilateral breast cancer: early detection with mammography. Radiology 196:427–431PubMed Roubidoux MA, Helvie MA, Lai NE, Paramagul C (1995) Bilateral breast cancer: early detection with mammography. Radiology 196:427–431PubMed
26.
go back to reference Berg WA (2009) Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol 192:390–399CrossRefPubMed Berg WA (2009) Tailored supplemental screening for breast cancer: what now and what next? AJR Am J Roentgenol 192:390–399CrossRefPubMed
27.
go back to reference Hou MF, Chuang HY, Ou-Yang F, Wang CY, Huang CL, Fan HM, Chuang CH, Wang JY, Hsieh JS, Liu GC, Huang TJ (2002) Comparison of breast mammography, sonography and physical examination for screening women at high risk of breast cancer in Taiwan. Ultrasound Med Biol 28:415–420CrossRefPubMed Hou MF, Chuang HY, Ou-Yang F, Wang CY, Huang CL, Fan HM, Chuang CH, Wang JY, Hsieh JS, Liu GC, Huang TJ (2002) Comparison of breast mammography, sonography and physical examination for screening women at high risk of breast cancer in Taiwan. Ultrasound Med Biol 28:415–420CrossRefPubMed
28.
go back to reference Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, Schnall MD (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295–1303CrossRefPubMed Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, Schnall MD (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295–1303CrossRefPubMed
29.
go back to reference Samant RS, Olivotto IA, Jackson JS, Mates D (2001) Diagnosis of metachronous contralateral breast cancer. Breast J 7:405–410CrossRefPubMed Samant RS, Olivotto IA, Jackson JS, Mates D (2001) Diagnosis of metachronous contralateral breast cancer. Breast J 7:405–410CrossRefPubMed
Metadata
Title
Diagnostic work-up of contralateral breast cancers has not improved over calendar period
Authors
Maria E. C. Sandberg
Mikael Hartman
Gustaf Edgren
Sandra Eloranta
Alexander Ploner
Per Hall
Kamila Czene
Publication date
01-08-2010
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0748-8

Other articles of this Issue 3/2010

Breast Cancer Research and Treatment 3/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine